2014 saw the introduction of a tamper-resistant, difficult to crush formulation of OxyContin, a strong opioid prescribed for chronic pain management as a response to growing concerns over its contribution to an increase in opioid use and related harms. A new study by the National Drug and Alcohol Research Centre at UNSW Sydney shows however that it has not had an effect on rates of opioid use or harms at a population level. Does Australia have an opiod crisis? Is tamper-resistant OxyContin the solution that we are looking for? Dr Briony Larance, Senior Research Fellow from the National Drug and Alcohol Research Centre at UNSW joined us on The Daily to talk about her research and what it tells us.